Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo

Cancer Letters

Volumn 245, Issue 1-2, 2007, Pages 232-241

  Thangapazham, Rajesh L ^a,b   Singh, Anoop K ^a   Sharma, Anuj ^a,b   Warren, James ^a   Gaddipati, Jaya P ^a   Maheshwari, Radha K ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

EGCG; Green tea; MDA MB 231; Tunel; Xenograft

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYCLINE; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; POLYPHENOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASIAN AMERICAN; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER REGRESSION; CANCER RISK; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TEA; TUMOR VOLUME; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CATECHIN; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; G1 PHASE; GUANOSINE TRIPHOSPHATE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; PHENOLS; PROLIFERATING CELL NUCLEAR ANTIGEN; TEA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; CAMELLIA SINENSIS; MUS MUSCULUS; THEACEAE;

EID: 33845636448     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.01.027     Document Type: Article

References (40)

1. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 (2003) 768-780
2. Hou Z., Lambert J.D., Chin K.V., and Yang C.S. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat. Res. 555 (2004) 3-19
3. Moyers S.B., and Kumar N.B. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr. Rev. 62 (2004) 204-211
4. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 21 (1992) 334-350
5. Stewart A.J., Mullen W., and Crozier A. On-line high-performance liquid chromatography analysis of the antioxidant activity of phenolic compounds in green and black tea. Mol. Nutr. Food Res. 49 (2005) 52-60
6. Adhami V.M., Siddiqui I.A., Ahmad N., Gupta S., and Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 64 (2004) 8715-8722
7. Caporali A., Davalli P., Astancolle S., D'Arca D., Brausi M., Bettuzzi S., et al. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 25 (2004) 2217-2224
8. Gupta S., Hastak K., Ahmad N., Lewin J.S., and Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl Acad. Sci. USA 98 (2001) 10350-10355
9. Saleem M., Adhami V.M., Ahmad N., Gupta S., and Mukhtar H. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin. Cancer Res. 11 (2005) 147-153
10. Sartor L., Pezzato E., Dona M., Dell'Aica I., Calabrese F., Morini M., et al. Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model. Int. J. Cancer 112 (2004) 823-829
11. Liao S., Umekita Y., Guo J., Kokontis J.M., and Hiipakka R.A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 96 (1995) 239-243
12. Bray F., McCarron P., and Parkin D.M. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 6 (2004) 229-239
13. Nakachi K., Suemasu K., Suga K., Takeo T., Imai K., and Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 89 (1998) 254-261
14. Wu A.H., Tseng C.C., Van Den Berg D., and Yu M.C. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res. 63 (2003) 7526-7529
15. Wu A.H., Yu M.C., Tseng C.C., Hankin J., and Pike M.C. Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer 106 (2003) 574-579
16. Yoneda T., Hiramatsu M., Sakamoto M., Togasaki K., Komatsu M., and Yamaguchi K. Antioxidant effects of 'beta catechin'. Biochem. Mol. Biol. Int. 35 (1995) 995-1008
17. Fassina G., Vene R., Morini M., Minghelli S., Benelli R., Noonan D.M., et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin. Cancer Res. 10 (2004) 4865-4873
18. Yamakawa S., Asai T., Uchida T., Matsukawa M., Akizawa T., and Oku N. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett. 210 (2004) 47-55
19. Mittal A., Pate M.S., Wylie R.C., Tollefsbol T.O., and Katiyar S.K. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int. J. Oncol. 24 (2004) 703-710
20. Tang F.Y., Nguyen N., and Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int. J. Cancer 106 (2003) 871-878
21. Zhu M., Chen Y., and Li R.C. Oral absorption and bioavailability of tea catechins. Planta Med. 66 (2000) 444-447
22. Kavanagh K.T., Hafer L.J., Kim D.W., Mann K.K., Sherr D.H., Rogers A.E., et al. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell Biochem. 82 (2001) 387-398
23. Sartippour M.R., Heber D., Ma J., Lu Q., Go V.L., and Nguyen M. Green tea and its catechins inhibit breast cancer xenografts. Nutr. Cancer 40 (2001) 149-156
24. Zhou J.R., Yu L., Mai Z., and Blackburn G.L. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int. J. Cancer 108 (2004) 8-14
25. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J. Clin. 55 (2005) 10-30
26. Borek C. Dietary antioxidants and human cancer. Integr. Cancer Ther. 3 (2004) 333-341
27. Awad A.B., Williams H., and Fink C.S. Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells. Nutr. Cancer 40 (2001) 157-164
28. Baliga M.S., Meleth S., and Katiyar S.K. Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin. Cancer Res. 11 (2005) 1918-1927
29. Zhang M., Binns C.W., and Lee A.H. Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 713-718
30. Pozo-Guisado E., Alvarez-Barrientos A., Mulero-Navarro S., Santiago-Josefat B., and Fernandez-Salguero P.M. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol. 64 (2002) 1375-1386
31. Jackson S.J., and Singletary K.W. Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 25 (2004) 219-227
32. Kim H.K., Park I.A., Heo D.S., Noh D.Y., Choe K.J., Bang Y.J., et al. Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer. Eur. J. Surg. Oncol. 27 (2001) 464-471
33. Nielsen N.H., Arnerlov C., Emdin S.O., and Landberg G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br. J. Cancer 74 (1996) 874-880
34. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671
35. Sausville E.A., Johnson J., Alley M., Zaharevitz D., and Senderowicz A.M. Inhibition of CDKs as a therapeutic modality. Ann. NY Acad. Sci. 910 (2000) 207-221 (discussion 221-2)
36. Gupta S., Hussain T., and Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch. Biochem. Biophys. 410 (2003) 177-185
37. Vergote D., Cren-Olive C., Chopin V., Toillon R.A., Rolando C., Hondermarck H., et al. (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Res. Treat. 76 (2002) 195-201
38. Hersey P., and Zhang X.D. Overcoming resistance of cancer cells to apoptosis. J. Cell Physiol. 196 (2003) 9-18
39. Johnstone R.W., Ruefli A.A., and Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108 (2002) 153-164
40. Kaufmann S.H., and Vaux D.L. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22 (2003) 7414-7430